Acer Therapeutics
Latest round
- Series B
Last raised
- May 2016
Total raised
- $12M
Investors
- 2
About Acer Therapeutics
Acer Therapeutics Inc.Founded in 2013 and headquartered in Newton, US, Acer Therapeutics Inc. specializes in therapies for rare and life-threatening diseases.Acer Therapeutics actively acquires, develops, and commercializes therapies for serious rare diseases. Its primary products include OLPRUVA™ (sodium phenylbutyrate) for Urea Cycle Disorders and EDSIVO™ (celiprolol) for vascular Ehlers-Danlos syndrome.26 mn. Specific future initiatives include the launch of additional therapies aimed at rare diseases, though no specific release dates are provided. The company is also targeting expansion into broader geographic markets to enhance accessibility for its patient base.
Who invested in Acer Therapeutics
2 investors across 2 rounds
See all investors in Acer Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Acer Therapeutics
Who invested in Acer Therapeutics?
Acer Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acer Therapeutics raised?
Acer Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Acer Therapeutics last raise money?
Acer Therapeutics's most recent round on record is a Series B, in May 2016.
What does Acer Therapeutics do?
Acer Therapeutics is a pharmaceuticals company.
Where is Acer Therapeutics headquartered?
Acer Therapeutics is headquartered in Newton, US.
Which VCs invest in companies like Acer Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Acer Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Acer Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.